張江高科(600895.SH):預計一季度淨利潤同比增長127%到177%
格隆匯4月8日丨張江高科(600895.SH)公佈,初步測算,預計2025年第一季度實現歸屬於上市公司股東的淨利潤爲2.7億元到3.3億元,與上年同期相比,將增加1.51億元到2.11億元,同比增長127%到177%。本期業績增長的主要原因爲:1、公司持續加強產業“投資+培育”力度,全力打造科技產業投資控股集團,公司下屬子公司所持金融資產估值上升,公司產業投資收益同比增加。2、公司全面提升產業服務能級,通過強化空間載體產業屬性,強化服務意識,助推產業載體租售率提升,營業收入同比增長24%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.